Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideCICigna
FinDog View：Neutral
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | CI | TMO |
|---|
| Close | 298.23 | 697.00 |
| Market Cap | $79.1B | $258B |
| 1M | +9.71% | +3.25% |
| P/E (TTM) | 12.4 | 36.4 |
| Forward P/E | 8.4 | 24.6 |
| P/E 5-Yr Percentile | 22 | 78 |
| P/S | 0.3 | 5.4 |
| P/B | 1.9 | 4.7 |
| Dividend Yield | 1.74% | 0.29% |
| Latest Quarter Revenue | $71.7B | $12.1B |
| Revenue YoY | +6.7% | +9.1% |
| Gross Margin | 20.9% | — |
| Latest Quarter EPS | 6.29 | 4.64 |
| Avg Post-Earnings Move | ±2.0% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.67% | 1.82% |
| 90-Day Net Insider Buying | −$6.3M | −$40.3M |
CI · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
